The Histopathology of braf -v600e–mutated Lung Adenocarcinoma

作者: Samuel A. Yousem , Marina Nikiforova , Yuri Nikiforov

DOI: 10.1097/PAS.0B013E31816597CA

关键词: AdenocarcinomaEpidermal growth factor receptorPathologyCancerCancer researchBiologyHistopathologyV600EMutationLung cancerKRAS

摘要: BRAF mutations in lung adenocarcinoma are much less common than the more frequently reported and mutually exclusive of KRAS EGFR genes, clinical histologic phenotype adenocarcinomas has not been described. We analyzed 222 lacking identified 10 with BRAF-V600E mutation. All were heterozygous. There was a slight female predilection (6:4) these elderly patients (average age 67 y) who found to have greater expected incidence intralobar satellite nodules N2 node involvement. The largely mixed type high papillary (80%) lepidic growth (50%). Adenocarcinomas this clinicopathologic may be worthwhile investigating for mutation as genetically oriented drug therapies emerge.

参考文章(20)
Marcia S Brose, Patricia Volpe, Michael Feldman, Madhu Kumar, Irum Rishi, Renee Gerrero, Eugene Einhorn, Meenhard Herlyn, John Minna, Andrew Nicholson, Jack A Roth, Steven M Albelda, Helen Davies, Charles Cox, Graham Brignell, Philip Stephens, P Andrew Futreal, Richard Wooster, Michael R Stratton, Barbara L Weber, None, BRAF and RAS mutations in human lung cancer and melanoma Cancer Research. ,vol. 62, pp. 6997- 7000 ,(2002)
Hideaki Tsutsumida, Mitsuharu Nomoto, Masamichi Goto, Shinichi Kitajima, Ichiro Kubota, Yasunobu Hirotsu, Joeji Wakimoto, Michael A Hollingsworth, Suguru Yonezawa, A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis Modern Pathology. ,vol. 20, pp. 638- 647 ,(2007) , 10.1038/MODPATHOL.3800780
Tatsuhiro Shibata, Satoko Hanada, Akiko Kokubu, Yoshihiro Matsuno, Hisao Asamura, Tsutomu Ohta, Michiie Sakamoto, Setsuo Hirohashi, Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma Cancer Science. ,vol. 98, pp. 985- 991 ,(2007) , 10.1111/J.1349-7006.2007.00483.X
Susan A. Silver, Frederic B. Askin, True Papillary Carcinoma of the Lung: A Distinct Clinicopathologic Entity The American Journal of Surgical Pathology. ,vol. 21, pp. 43- 51 ,(1997) , 10.1097/00000478-199701000-00005
Jenifer L. Marks, Michael D. McLellan, Maureen F. Zakowski, Alex E. Lash, Yumi Kasai, Stephen Broderick, Inderpal S. Sarkaria, DuyKhanh Pham, Bhuvanesh Singh, Tracie L. Miner, Ginger A. Fewell, Lucinda L. Fulton, Elaine R. Mardis, Richard K. Wilson, Mark G. Kris, Valerie W. Rusch, Harold Varmus, William Pao, Mutational Analysis of EGFR and Related Signaling Pathway Genes in Lung Adenocarcinomas Identifies a Novel Somatic Kinase Domain Mutation in FGFR4 PLOS ONE. ,vol. 2, ,(2007) , 10.1371/JOURNAL.PONE.0000426
Takehito Kawakami, Kazuki Nabeshima, Yoshifumi Makimoto, Makoto Hamasaki, Akinori Iwasaki, Takayuki Shirakusa, Hiroshi Iwasaki, Micropapillary pattern and grade of stromal invasion in pT1 adenocarcinoma of the lung: usefulness as prognostic factors. Modern Pathology. ,vol. 20, pp. 514- 521 ,(2007) , 10.1038/MODPATHOL.3800765
Adebowale J Adeniran, Zhaowen Zhu, Manoj Gandhi, David L Steward, James P Fidler, Thomas J Giordano, Paul W Biddinger, Yuri E Nikiforov, Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. The American Journal of Surgical Pathology. ,vol. 30, pp. 216- 222 ,(2006) , 10.1097/01.PAS.0000176432.73455.1B
Vítor Trovisco, Paula Soares, Manuel Sobrinho-Simões, B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas Human Pathology. ,vol. 37, pp. 781- 786 ,(2006) , 10.1016/J.HUMPATH.2006.03.013
N. KURODA, N. HAMAGUCHI, E. TAKEUCHI, M. OHARA, T. HIROUCHI, K. MIZUNO, Lung adenocarcinoma with a micropapillary pattern: a clinicopathological study of 25 cases Apmis. ,vol. 114, pp. 381- 385 ,(2006) , 10.1111/J.1600-0463.2006.APM_340.X
David B. Solit, Levi A. Garraway, Christine A. Pratilas, Ayana Sawai, Gad Getz, Andrea Basso, Qing Ye, Jose M. Lobo, Yuhong She, Iman Osman, Todd R. Golub, Judith Sebolt-Leopold, William R. Sellers, Neal Rosen, BRAF mutation predicts sensitivity to MEK inhibition Nature. ,vol. 439, pp. 358- 362 ,(2006) , 10.1038/NATURE04304